Chemistry: analytical and immunological testing – Nuclear magnetic resonance – electron spin resonance or other...
Patent
1993-03-05
1995-10-17
Housel, James C.
Chemistry: analytical and immunological testing
Nuclear magnetic resonance, electron spin resonance or other...
324307, 324312, 436 86, 436172, 530315, 530316, G01N 2408
Patent
active
054590779
ABSTRACT:
Disclosed are methods for modelling the three-dimensional structure (tertiary structure) of a ligand having one or more active sites employing a charge-transfer interaction. Also disclosed is a model for Angiotensin II derived from such method.
REFERENCES:
patent: 3751404 (1973-08-01), Sipos et al.
patent: 4355040 (1982-10-01), Furukawa et al.
patent: 4386026 (1983-05-01), Ponpipom et al.
patent: 4485177 (1984-11-01), Siedel et al.
patent: 4578361 (1986-03-01), Siedel et al.
patent: 4702864 (1987-10-01), Maegolda et al.
patent: 4772684 (1988-09-01), Brunck et al.
patent: 4789832 (1988-12-01), Nagayama
patent: 4818684 (1989-04-01), Edelman et al.
patent: 4822746 (1989-04-01), Walt
patent: 4830961 (1989-05-01), Petty
patent: 4845075 (1989-07-01), Murray et al.
patent: 4849407 (1989-07-01), Murray et al.
patent: 4853871 (1989-08-01), Pantoliano et al.
patent: 5015651 (1991-05-01), Carini et al.
patent: 5043349 (1991-08-01), Carini et al.
Chem, Abstr. 1974, 81, Abstract No. 81:46793m.
Chem. Abstr. 1976, 85, Abstract No. 85:160476t.
Chem. Abstr. 1978, 88, Abstract No. 88:148329b.
Chem. Abstr. 1982, 96, Abstract No. 96:123275h.
Chem. Abstr. 1987, 107, Abstract No. 107:90191t.
Otter et al. "Solution Conformation of N-Acetyl-L-prolyl-glutaminyl-L-prolyl-L-prolyl-L-glutaminamide, a Pentapeptide Fragment of the Type I Collagen .alpha.-1 Chain C-Telopeptide, Determined by Phase-Sensitive Two Dimensional NMR Techniques" J. Am. Chem. Soc. 1987, 109, 6995-7001.
Steve Cheatham "Nuclear Magnetic Resonance Spectroscopy in Biochemistry" J. Chem. Ed. 1989, 66, 111-117.
Surewicz et al. "Conformational Properties of Angiotensis II in Aqueous Solution and in a Lipid Environment: A Fouvier Transform Infrared Spectroscopic Investigation" J. Am. Chem. Soc. 1988, 4412-4414.
Deranleau, D. A. J. Am. Chem. Soc. 1975, 97, 1218-1224.
Wombacher, H. et al. Z. Naturforsh. 1976, 31, 18-20.
Grinvald, A. et al. Biochim. Biophys. Acta 1976, 427, 663-678.
Mayer, R. et al. J. Bio. Chem. 1979, 254, 75-82.
Lown, J. W. et al. J. Am. Chem. Soc. 1982, 104, 3214-3216.
Tran, C. D. et al. J. Am. Chem. Soc. 1982, 104, 3002-3007.
Kanellis, P. et al. Arch. Biochem. Biophys. 1983, 220, 530-540.
Marion, D. et al. Biochem. Biophys. Res. Commun. 1983, 113, 967-974.
J. D. Glickson et al. Pept. Proc. Am. Pept. Symp., 5th 1977, 325-328.
J. P. Demonte et al. Int. J. Pept. Protein Res. 1981, 18, 478-486.
H. Tanaka et al. Pept. Chem. 1985 (Pub. 1986) 24rd, 311-316.
W. R. Laws et al. Biochemistry 1986, 25, 599-607.
C. O. Pabo et al. Biochemistry 1986, 25, 5987-5991.
M. C. Fournie-Zaluski et al. Pept. Proc. Eur. Pepti Symp, 19th 1986, 345-348.
G. Bovermann et al. Pept. Proc. Eur. Pept. Symp. 19th, 1986, 311-314.
G. V. Nikiforovich et al, J. Biomol. Struct. Dyn. 1987, 4, 1119-1135.
R. T. Gampe et al. Biopolymers 1988, 27, 313-321.
R. T. Science 1992, 256, 441.
J. S. Dixon Trends Biochem. 1992, 10, 357-363.
Moore, et al, "Angiotensin as a model for hormone--receptor interactions", Bioscience Reports, vol. 5 (1985), pp. 407-416.
Moore, et al, "Structure-desensitization relationships of angiotensin analogues in the rat isolated uterus", Can. J. Physiol. Pharmacol., vol. 63 (1985), pp. 966-991.
Matsoukas, et al, "Proton Magnetic Resonance Studies of Angiotensin II Conformation: cis-trans Isomerism in Sarcosine.sup.7 -Containing Analogs", Archives of Biochemistry and Biophysics, vol. 248, No. 1 (1986), pp. 419-423.
Rauk, et al, "Mechanistic Consequences of Charge Transfer Systems in Serine Proteases and Angiotensin: Semiempirical Computations", Biochemical and Biophysical Research Communications, vol. 145, No. 3 (1987), pp. 1349-1355.
Matsoukas, et al, "NMR and Mass Spectroscopic Studies of the Competitive Angiotensin II Antagonist `Sarmesin`", Spectroscopy Letters, vol. 21, No. 5 (1988), pp. 477-491.
Moore, et al, "Methods for Analyzing and Interpreting Cooperativity in Dose-Response Curves-I. Antagonist Effects on Agiotensin Receptors in Smooth Muscle", General Pharmacology, vol. 20, No. 2 (1989), pp. 193-198.
Moore, et al, "Angiotensin `Antipeptides`: (-)Messenger RNA Complementary to Human Angiotensin II (+)Messenger RNA Encodes an Angiotensin Receptor Antagonist", Biochemical and Biophysical Research Communications, vol. 160, No. 3 (1989), pp. 1387-1391.
Fisher, et al., Biochemistry, "1H NMR Studies of Bovine and Porcine Phospholipase A2: Assignment of Aromatic Resonances and Evidence for a Conformational Equilibrium in Solution", 28(11):5939-5946 (1989).
Moore, et al., Biochemistry, ".sup.1 H NMR Studies of Plastocyanin from Scenedesmus obliquus: Complete Sequence-Specific Assignment, Secondary Analysis, and Global Fold", 27:7806-7816 (1988).
Ostrovskii, et al., Soviet Journal of Quantum Electronics, "Investigation of the Dynamics of the Structure of Biopolymers by the Method of Kinetic Spectrofluorometry", 16:772-775 (1986).
Kaiser, et al, Science, "Amphiphilic Secondary Structure: Design of Peptide Hormones" 223:249-255 (1984).
Chemical Abstracts, vol. 100, No. 23, 4 Jun. 1984, Abstract No. 192245m.
Chemical Abstracts, vol. 104, No. 21, 26 May 1986, Abstract No. 182239f.
Chemical Abstracts, vol. 97, No. 1, 5 Jul. 1982, Abstract No. 2458g.
Chemical Abstracts, vol. 102, No. 23, 10 Jun. 1985, Abstract No. 204280a.
Moore, International Journal of Peptide and Protein Research, "Kinetices of Acetylation-Deacetylation of Angiotensin II", 26(5):469-481 (1985).
Matsoukas, et al., J. Med. Chem., "Importance of the N-terminal Domain of the Type II Aniotensin Antagonist Sarmesin for Receptor Blockade", 31(7):1418-1421 (1988).
Duncia, et al., J. Med. Chem., "The discovery of Potent Non-Peptide Angiotensin II Receptor Antagonists: A New Class of Potent Antihypertensives", 33(5):1312-1329 (1990).
Carini, et al., J. Med. Chem., "Nonpeptide Angiotensin II Receptor Antagonists: N-[(Benzyloxy)benzyl]imida-zoles and Related Compounds as Potent Antihyper-tensives", 33:1330-1336 (1990).
Chary, et al., "Molecular Conformation of Gonadoliberin Using Two-Dimensional NMR Spectroscopy", Eur. J. Biochem., 158:323-322 (1986).
Skoog and West, "Principles of Instrumental Analysis", 2nd Edition, pp. 280-297.
Goghari, et al, "Structure-Activity Relationships for the Competitive Angiotensin Antagonist [Saricosine.sup.1, O-methyltyrosine.sup.4 ] angiotensin II (Sarmesin)", Journal of Medicinal Chemistry, vol. 29, No. 6 (1986), pp. 1121-1124.
Matsoukas, et al, "Synthesis and Biological Activities of Analogues of Angiotensin II and III Containing O-Methyltyrosine and D-Tryptophan", Journal of Medicinal Chemistry, vol. 28, No. 6 (1985), pp. 780-783.
Wong, et al, "Nonpeptide Angiotensin II Receptor Antagonists. IV. EXP6155 and EXP6803", Hypertension, vol. 13, No. 5 (May 1989), pp. 489-497.
Kessler, et al, "Separation of Cross-Relaxation and J Cross-Peaks in 2D Rotating-Frame NMR Spectroscopy", Journal of American Chemical Society, vol. 109, No. 2 (1987), pp. 607-609.
Moore, et al, "Synthesis of Angiotensin II Antagonists Containing Sarcosine in Position 7", Journal of Medicinal Chemistry, vol. 22, No. 9 (1979), pp. 1147-1149.
Scanlon, et al, "A New Approach to Angiotensin Antagonists: Methylation of the Tyrosine Hydroxyl in Angiotensin II", Life Sciences, vol. 34, No. 4 (1984), pp. 317-321.
Higashijima, T. et al, Eur. J. Biochem. 1984, 140, 163-171.
Ross, J. B. A. et al. Biochemistry, 1986, 25, 607-612.
Devaux, P. F. et al. Biochem. Biophys. Acta 1985, 822, 63-125.
Hass, E. et al. Biochemistry, 1987, 26, 1672-1683.
Weaver, A. J. et al. Biochemistry, 1989, 28, 8614-8623.
Weaver, A. J. et al. Biochemistry 1989, 28, 8624-8639.
Chemical Abstracts 1987, 107, Abstract No. 107:147522h.
Chem. Abstr. 1987, 107, Abstract No. 107:147524k.
Matsoukas John M.
Moore Graham J.
Housel James C.
PepMetics, Inc.
Sodenquist Arlen
LandOfFree
Methods for modelling tertiary structures of biologically active does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for modelling tertiary structures of biologically active, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for modelling tertiary structures of biologically active will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-596810